FRANKLIN, Tenn.--(BUSINESS WIRE)--Aug. 9, 2006--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today reported its financial results for the three months and six months ended June 30, 2006. For the three months ended June 30, 2006, the Company reported a net loss attributable to common stockholders of $3.9 million or $0.42 per share compared to a net loss of $1.4 million, or $0.89 per share for the same period in 2005. In May 2006, the Company completed its initial public offering (IPO), raising $36.8 million in gross proceeds through the sale of 4.6 million shares. The Company ended the second quarter with $58.5 million in cash and cash equivalents.
